Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 20/20 | 0.64 |
| ▸ | AKT2 | P31751 | 20/20 | 0.64 |
| ▸ | AKT3 | Q9Y243 | 20/20 | 0.64 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.51 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2555510 | 1.00 | AKT1 (0.64) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL12813078 | 0.94 | AKT1 (0.56) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL12813055 | 0.93 | AKT1 (0.54) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL12812964 | 0.93 | AKT1 (0.54) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2556676 | 0.92 | AKT1 (0.54) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2554236 | 0.92 | AKT1 (0.54) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2555500 | 0.90 | AKT1 (0.61) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2558152 | 0.90 | AKT1 (0.61) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL2552068 | 0.90 | AKT1 (0.52) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL12813075 | 0.90 | AKT1 (0.66) | AKT1AKT2AKT3PIK3CAPRKG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2959014-A2 | METHODS AND COMPOSITIONS FOR DETECTING AND TREATING DRUG RESISTANT AKT MUTANT | Genentech, Inc. (US) | 2015-12-30 | — | — | EP | disclosed |
| WO-2014130923-A2 | METHODS AND COMPOSITIONS FOR DETECTING AND TREATING DRUG RESISTANT AKT MUTANT | GENENTECH, INC. (US) | 2014-08-28 | — | — | WO | disclosed |
| EP-2694959-A2 | BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS | Genentech, Inc. (US) | 2014-02-12 | — | — | EP | disclosed |
| EP-2558864-A1 | FOX03A AS PREDICTIVE BIOMARKER FOR PI3K/AKT KINASE PATHWAY INHIBITOR EFFICACY | Genentech, Inc. (US) | 2013-02-20 | — | — | EP | disclosed |
| WO-2012135749-A2 | BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS | GENENTECH, INC. (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2011130654-A1 | FOX03A AS PREDICTIVE BIOMARKER FOR PI3K/AKT KINASE PATHWAY INHIBITOR EFFICACY | GENENTECH, INC. (US) | 2011-10-20 | — | — | WO | disclosed |